Respiratory symptoms and chronic bronchitis in people with and without HIV infection

C A Sabin, K M Kunisaki, E Bagkeris, F A Post, M Sachikonye, M Boffito, J Anderson, Pwg Mallon, I Williams, J H Vera, M Johnson, D Babalis, A Winston, C A Sabin, K M Kunisaki, E Bagkeris, F A Post, M Sachikonye, M Boffito, J Anderson, Pwg Mallon, I Williams, J H Vera, M Johnson, D Babalis, A Winston

Abstract

Objectives: High rates of respiratory symptoms and chronic bronchitis (CB) are reported in people with HIV infection (PWH). We investigated the prevalence of respiratory symptoms and CB in PWH and HIV-negative people in the Pharmacokinetic and clinical Observations in PeoPle over fiftY (POPPY) study.

Methods: Assessment of respiratory symptoms and CB was undertaken using the modified form of the St. George's Respiratory Questionnaire for chronic obstructive pulmonary disease (COPD). Univariate (χ2 tests, Mann-Whitney U tests and Spearman's rank correlation) and multivariable (linear and logistic regression) analyses were performed to consider associations of respiratory symptoms with demographic, lifestyle and HIV-related parameters, and with depressive symptoms and quality of life.

Results: Among the 619 participants, respiratory Symptom scores were higher in older and younger PWH compared to older HIV-negative people, with median (interquartile range) scores of 17.7 (6.2, 39.5), 17.5 (0.9, 30.0) and 9.0 (0.9, 17.5), respectively (P = 0.0001); these differences remained significant after confounder adjustment. Sixty-three participants (10.2%) met the criteria for CB [44 (14.0%) older PWH, 14 (9.2%) younger PWH, and five (3.3%) older HIV-negative people; P = 0.002], with these differences also remaining after adjustment for confounding variables, particularly smoking status [older vs. younger PWH: odds ratio (OR) 4.48 (95% confidence interval (CI) 1.64, 12.30); P = 0.004; older PWH vs. HIV-negative people: OR 4.53 (95% CI 1.12, 18.28); P = 0.03]. Respiratory symptoms and CB were both associated with greater depressive symptom scores and poorer quality of life. No strong associations were reported between CB and immune function, HIV RNA or previous diagnosis of any AIDS event.

Conclusions: Respiratory symptoms and CB are more common in PWH than in demographically and lifestyle-similar HIV-negative people and are associated with poorer mental health and quality of life.

Keywords: HIV infection; chronic bronchitis; immunosuppression; patient-reported outcome measures; respiratory symptoms.

© 2020 The Authors. HIV Medicine published by John Wiley & Sons Ltd on behalf of British HIV Association.

References

    1. May MT, Gompels M, Delpech V et al. Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy. AIDS 2014; 28: 1193-1202.
    1. Marcus JL, Chao CR, Leyden WA et al. Narrowing the gap in life expectancy between HIV-infected and HIV-uninfected individuals with access to care. J Acquir Imm Defic Syndr 2016; 73: 39-46.
    1. Smit M, Brinkman K, Geerlings S et al. Future challenges for clinical care of an ageing population infected with HIV: a modelling study. Lancet Infect Dis 2015; 15: 810-818.
    1. Brown J, Roy A, Harris R et al. Respiratory symptoms in people living with HIV and the effect of antiretroviral therapy: a systematic review and meta-analysis. Thorax 2017; 72: 355-366.
    1. Fitzpatrick ME, Kunisaki KM, Morris A. Pulmonary disease in HIV-infected adults in the era of antiretroviral therapy. AIDS 2018; 32: 277-292.
    1. Kunisaki KM, Niewoehner DE, Collins G et al. Pulmonary effects of immediate versus deferred antiretroviral therapy in HIV-positive individuals: a nested substudy within the multicentre, international, randomised, controlled Strategic Timing of Antiretroviral Treatment (START) trial. Lancet Respir Med 2016; 4: 980-989.
    1. American Lung Association. Trends in COPD (chronic bronchitis and emphysema): morbidity and mortality, 2013. (accessed 15th October 2019).
    1. Kim V, Criner GJ. The chronic bronchitis phenotype in chronic obstructive pulmonary disease: features and implications. Curr Opin Pulm Med 2015; 21: 133-141.
    1. Celis-Morales CA, Welsh P, Lyall DM et al. Associations of grip strength with cardiovascular, respiratory, and cancer outcomes and all cause mortality: prospective cohort study of half a million UK Biobank participants. BMJ 2018; 361: k1651.
    1. Weinberger AH, Smith PH, Funk AP, Rabin S, Shuter J. Sex differences in tobacco use among persons living with HIV/AIDS: a systematic review and meta-analysis. J Acquir Immune Defic Syndr 2017; 74: 439-453.
    1. Petoumenos K, Law MG. Smoking, alcohol and illicit drug use effects on survival in HIV-positive persons. Curr Opin HIV AIDS 2016; 11: 514-520.
    1. Bagkeris E, Burgess L, Mallon PW et al. Cohort profile: the Pharmacokinetic and clinical Observations in PeoPle over fiftY (POPPY) Study. Int J Epidemiol 2018; 47: 1391-1392e.
    1. UK Chic Study Steering Committee. The creation of a large UK-based multicentre cohort of HIV-infected individuals: The UK Collaborative HIV Cohort (UK CHIC) Study. HIV Med 2004; 5: 115-124.
    1. McGettrick P, Ghavami-Kia B, Tinago W et al. The HIV Care Cascade and sub-analysis of those linked to but not retained in care: the experience from a tertiary HIV referral service in Dublin Ireland. HIV Clin Trials 2017; 18: 93-95.
    1. Jones George’s Respiratory Questionnaire for COPD Patients (SGRQ-C). Manual. (accessed 3rd January 2020).
    1. Kim V, Crapo J, Zhao H et al. Comparison between an alternative and the classic definition of chronic bronchitis in COPDGene. Ann Am Thorac Soc 2015; 12: 332-339.
    1. Jones PW. St. George’s Respiratory Questionnaire: MCID. COPD 2005; 2: 75-79.
    1. Leung JM, Liu JC, Mtambo A et al. The determinants of poor respiratory health status in adults living with human immunodeficiency virus infection. AIDS Pat Care and STDs 2014; 28: 240-247.
    1. Kunisaki KM, Nouraie M, Jensen RL et al. Lung function in men with and without HIV. AIDS 2020; 34: 1227-1235.
    1. Bigna JJ, Kenne AM, Asangbeh SL, Sibetcheu AT. Prevalence of chronic obstructive pulmonary disease in the global population with HIV: a systematic review and meta-analysis. Lancet Glob Health 2018; 6: e193-e202.
    1. Risso K, Guillouet-de-SalvadorF Valerio L et al. COPD in HIV-infected patients: CD4 cell count highly correlated. PLoS One 2017; 12 (1): e0169359.
    1. Depp TB, McGinnis KA, Kraemer K et al. Risk factors associated with acute exacerbation of chronic obstructive pulmonary disease in HIV-infected and uninfected patients. AIDS 2016; 30: 455-463.
    1. Chinnapaiyan S, Dutta RK, Nair M, Chand HS, Rahman I, Unwalla HJ. TGF-β1 increases viral burden and promotes HIV-1 latency in primary differentiated human bronchial epithelial cells. Sci Rep 2019; 9: 12552.
    1. Chelvanambi S, Bogatcheva NV, Bednorz M et al. HIV-Nef Protein Persists in the Lungs of Aviremic Patients with HIV and Induces Endothelial Cell Death. Am J Respir Cell Mol Biol 2019; 60: 357-366.
    1. Simenauer A, Assefa B, Rios-Ochoa J et al. Repression of Nrf2/ARE regulated antioxidant genes and dysregulation of the cellular redox environment by the HIV Transactivator of Transcription. Free Radic Biol Med 2019; 141: 244-252.
    1. Yang L, Dunlap DG, Qin S et al. Alterations in Oral Microbiota in HIV are Related to Decreased Pulmonary Function. Am J Respir Crit Care Med 2020; 201: 445-457.
    1. Xu S, Tsai A, Sze MA et al. Decreased microbiome diversity in the HIV small airway epithelium. Respir Res 2018; 19: 140.
    1. Pelkonen MK, Notkola IK, Laatikainen TK, Jousilahti P. Chronic bronchitis in relation to hospitalization and mortality over three decades. Respir Med 2017; 123: 87-93.
    1. Chen W, Thomas J, Sadatsafavi M, FitzGerald JM. Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Lancet Respir Med 2015; 3: 631-639.
    1. Gingo MR, Nouraie M, Kessinger CJ et al. Decreased lung function and all-cause mortality in HIV-infected individuals. Ann Am Thorac Soc 2018; 15: 192-199.
    1. Triplette M, Justice A, Attia EF et al. Markers of chronic obstructive pulmonary disease are associated with mortality in people living with HIV. AIDS 2018; 32: 487-493.
    1. Campo M, Oursler KK, Huang L et al. Association of chronic cough and pulmonary function with 6-minute walk test performance in HIV infection. J Aquir Imm Defic Syndr 2014; 65: 557-563.
    1. Guo J, Chen Y, Zhang W, Tong S, Dong J. Moderate and severe exacerbations have a significant impact on health-related quality of life, utility, and lung function in patients with chronic obstructive pulmonary disease: a meta-analysis. Int J Surg 2020; 78: 28-35.
    1. Adams RJ, Appleton SL, Wilson DH, Taylor AW, Ruffin RE. Associations of physical and mental health problems with chronic cough in a representative population cohort. Cough 2009; 5: 10.
    1. Forey BA, Thonton AJ, Lee PN. Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema. BMC Pulm Med 2011; 11: 36.
    1. MacDonald DM, Melzer AC, Collins G et al. Smoking and Accelerated Lung Function Decline in HIV-Positive Individuals: A Secondary Analysis of the START Pulmonary Substudy. J Acquir Imm Defic Syndr 2018; 79: e85-e92.
    1. Crothers K, Goulet JL, Rodriguez-Barradas MC et al. Impact of cigarette smoking on mortality in HIV-positive and HIV-negative veterans. AIDS Educ Prev 2009; 32 (3 Suppl): 40-53.
    1. Reddy KP, Parker RA, Losina E et al. Impact of cigarette smoking and smoking cessation on life expectancy among people with HIV: A US-based modeling study. J Infect Dis 2016; 214: 1672-1681.
    1. Helleberg M, May MT, Ingle SM et al. Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America. AIDS 2015; 29: 221-9.
    1. Ferrer M, Villasante C, Alonso J et al. Interpretation of quality of life scores from the St. George’s Respiratory Questionnaire. Eur Respir J 2002; 19: 405-413.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa